Orum Therapeutics, Inc. operates as a biotechnology company. It engages in the development of treatments for cancer and immune diseases. The company was founded by Seung-Ju Lee and Yong-Sung Kim on August 17, 2016 and is headquartered in Daejeon, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company